ReNeuron starts stem cell stroke study
This article was originally published in Clinica
Executive Summary
The first patient has been treated in a study of ReNeuron's stem cell therapy, ReN001. Called PISCES, the trial is the world's first using expanded neural stem cells in stroke, and the first stem cell-based trial in the UK.